Candesartan differentially regulates epithelial sodium channel in cortex versus medulla of streptozotocin-induced diabetic rats

Journal of Epithelial Biology and Pharmacology

Volumn 2, Issue 1, 2009, Pages 23-29

  Klein, Janet D ^a   Rash, Arjun ^b   Sands, Jeff M ^a   Ecelbarger, Carolyn M ^b   Tiwari, Swasti ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin receptor; AT1R antagonist; Epithelial transporters

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CANDESARTAN; DRINKING WATER; EPITHELIAL SODIUM CHANNEL; PROTEIN; SODIUM CHLORIDE COTRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; IMMUNOBLOTTING; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; UPREGULATION;

RATTUS;

EID: 77953412174     PISSN: None     EISSN: 18750443     Source Type: Journal    
DOI: 10.2174/1875044300902010023     Document Type: Article

References (29)

1. Song J, Knepper MA, Verbalis JG, Ecelbarger CA. Increased renal ENaC subunit and sodium transporter abundances in streptozotocin- induced type 1 diabetes. Am J Physiol Renal Physiol 2003; 285(6): F1125-37. (Pubitemid 37421049)
2. Kim D, Sands JM, Klein JD. Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats. Am J Physiol Renal Physiol 2003; 285(2): F303-F309. (Pubitemid 36871203)
3. Beutler KT, Masilamani S, Turban S, et al. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003; 41(5): 1143-1150 (Pubitemid 36548617)
4. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002; 13(5): 1131-1135
5. Alvarez de la Rosa D, Li H, Canessa CM. Effects of aldosterone on biosynthesis, traffic, and functional expression of epithelial sodium channels in A6 cells. J Gen Physiol 2002; 119(5): 427-442 (Pubitemid 34522289)
6. Blazer-Yost BL, Liu X, Helman SI. Hormonal regulation of ENaCs: insulin and aldosterone. Am J Physiol 1998; 274(5 Pt 1): C1373-9. (Pubitemid 28255788)
7. Madala Halagappa VK, Tiwari S, Riazi S, Hu X, Ecelbarger CM. Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat. Am J Physiol Renal Physiol 2008; 294(5): F1222-31.
8. Blount MA, Sands JM, Kent KJ, Smith TD, Price SR, Klein JD. Candesartan augments compensatory changes in medullary transport proteins in the diabetic rat kidney. Am J Physiol Renal Physiol 2008; 294(6): F1448-52.
9. Topcu SO, Pedersen M, Norregaard R, et al. Candesartan prevents long-term impairment of renal function in response to neonatal par tial unilateral ureteral obstruction. Am J Physiol Renal Physiol 2007; 292(2): F736-48. (Pubitemid 46220542)
10. Noda M, Matsuo T, Nagano-Tsuge H, et al. Involvement of angiotensin II in progression of renal injury in rats with genetic noninsulin- dependent diabetes mellitus (Wistar fatty rats). Jpn J Pharmacol 2001; 85(4): 416-422 (Pubitemid 32421733)
11. Sugimoto K, Tsuruoka S, Matsushita K, Fujimura A. Effects of candesartan cilexetil on oxidative state and renal function in 5/6 nephrectomized rats. J Hum Hypertens 1999; 13(Suppl 1): S63-70; discussion S81. (Pubitemid 29057660)
12. Tiwari S, Packer RK, Hu X, Sugimura Y, Verbalis JG, Ecelbarger CA. Increased renal alpha-ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape. Am J Physiol Renal Physiol 2006; 291(1): F49-57. (Pubitemid 43945935)
13. Tiwari S, Nordquist L, Halagappa VK, Ecelbarger CA. Trafficking of ENaC subunits in response to acute insulin in mouse kidney. Am J Physiol Renal Physiol 2007; 293(1): F178-85. (Pubitemid 47345016)
14. Nielsen J, Kwon TH, Praetorius J, et al. Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI. Am J Physiol Renal Physiol 2003; 285(6): F1198-209. (Pubitemid 37421056)
15. Pawelczyk T, Grden M, Rzepko R, Sakowicz M, Szutowicz A. Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. Am J Pathol 2005; 167(2): 315-325 (Pubitemid 43026089)
16. Uehara T, Miyoshi T, Tsuchiya N, et al. Comparative analysis of gene expression between renal cortex and papilla in nedaplatininduced nephrotoxicity in rats. Hum Exp Toxicol 2007; 26(10): 767-780 (Pubitemid 350221391)
17. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003; 46(8): 1153-1160 (Pubitemid 37041246)
18. Palm F, Friederich M, Carlsson PO, Hansell P, Teerlink T, Liss P. Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability. Am J Physiol Renal Physiol 2008; 294(1): F30-7.
19. Riazi S, Maric C, Ecelbarger CA. 17-β estradiol attenuates streptozotocin- induced diabetes and regulates the expression of renal sodium transporters. Kidney Int 2006; 69(3): 471-480 (Pubitemid 43164438)
20. Vidotti DB, Arnoni CP, Maquigussa E, Boim MA. Effect of longterm type 1 diabetes on renal sodium and water transporters in rats. Am J Nephrol 2008; 28(1): 107-114 (Pubitemid 350126500)
21. Ziyadeh FN, Hoffman BB, Han DC, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000; 97(14): 8015-8020
22. Ahloulay M, Schmitt F, Dechaux M, Bankir L. Vasopressin and urinary concentrating activity in diabetes mellitus. Diabetes Metab 1999; 25(3): 213-222 (Pubitemid 29426372)
23. Iwasaki Y, Kondo K, Murase T, Hasegawa H, Oiso Y. Osmoregulation of plasma vasopressin in diabetes mellitus with sustained hyperglycemia. J Neuroendocrinol 1996; 8(10): 755-760 (Pubitemid 26331798)
24. Ecelbarger CA, Kim GH, Terris J, et al. Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. Am J Physiol Renal Physiol 2000; 279(1): F46-53. (Pubitemid 30619545)
25. Trinder D, Stephenson JM, Gao X, Phillips PA, Risvanis J, Johnston CI. [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand. Peptides 1991; 12(6): 1195-1200
26. Phillips PA, Abrahams JM, Kelly JM, Mooser V, Trinder D, Johnston CI. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Endocrinology 1990; 126(3): 1478-1484 (Pubitemid 20095752)
27. Harrison-Bernard LM, Imig JD, Carmines PK. Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res 2002; 3(2): 97-108.
28. Brooks HL, Allred AJ, Beutler KT, Coffman TM, Knepper MA. Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice. Hypertension 2002; 39(2 Pt 2): 470-473
29. Khadouri C, Barlet-Bas C, Doucet A. Mechanism of increased tubular Na-K-ATPase during streptozotocin-induced diabetes. Pflugers Arch 1987; 409(3): 296-301. (Pubitemid 17096107)